Vertex Pharmaceuticals (VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ ...
Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...
In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...
Equity markets performed well in January, as they often do, but as the dust settles on that early-year run, the strategy for ...
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
By Rick Winterson Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge. It has now established its global headquarters on Fan Pier in South ...
The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...
Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...
SALT LAKE CITY, UTAH / ACCESS Newswire / February 6, 2025 /CenExel, a leading network of clinical research sites, proudly ...
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
US FDA has approved its first ever non-opioid painkiller called suzetrigine. Experts believe it will prevent addiction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results